definiens: means any pharmaceutical product which contains Benzoporphyrin derivative as an active ingredient for use in PDT and, for greater certainty, includes Verteporfin ; 1.1.11 means a day that is not a Saturday or Sunday or a national holiday in either Canada or Switzerland ; 1.1.12 means the respective periods of three ( 3 ) consecutive calendar months ending on March 31, June 30, Septenlber 30, and December 31 ; provided, however, that ( a ) the first Calendar Quarter of the term of this Agreement after the Restatement Date will extend from the Restatement Date to the end of the first complete Calendar Quarter thereafter ; and ( b ) the last Calendar Quarter will end upon the expiration or termination of this Agreement ; 1.1.13 or t ~ isAgreement, that such . party has not sold any Product in such country for a period [ longer:'t.~ansii:(6j;consecuHYe'montlis ], except if ( i ) the parties agree otherwise or ( ii ) [ such lackor'sales is attributable to the schedule on which a goverIlmentpurchaserpurchases the Visudyne Pro ~ uct in such country, e.g., on on'e-~m~, oraD inf.f : equent, bas ~ s:<Iuringagi .. with " .., .. ~minglorisimilar pur¢hases : by : such gove : m ~ el1 t purclias ~ r'occurring more than ' ~,ix ( ~ ) ' Iti~~.hs ~p ~ rt ] or ( iii ) such lack of sales is attributable to an event of force majeure ( or in the case of [COMPANY], the failure by [COMPANY] to supply Product ) ; 1.1.14 has the meaning set out in [ Section ~.40(B)(4 ) ] ; 1.1.15, or means the legal authority or right of a party to grant a license or sublicense as provided for herein without violating the terms of any agreement or other arrangement with any Third Party or misappropriating the proprietary or trade secret information of a Third Party ; 1.1.16 has the meaning set out in Section 3.8.2 ; 1.1.17 means with respect to any Product prior to the Transition Effective Date all work carried out in accordance with a Development Program, including non­clinical and clinical studies, required to obtain health regulatory approvals in all countries in the Territory determined to be necessary or desirable by the JCC and all subsequent work prior to the Transition Effective Date required to maintain or defend such approval, and premarketing activities conducted prior to such approval ; 1.1.18 means those costs and expenses, comprised of Labour and Third Party Costs, incurred subsequent to the Effective Date and prior to the Transition Effective Date in accordance with Section 15 that have been approved by the JCC from time to time, and, unless otherwise determined by the JCC, shall include the following : 1 . costs of Labour employed on Development Programs including regulatory work and preparation of submissions ; 1 * ) Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission . Confidential treatment has been requested with respect to the omitted portions